Health
AstraZeneca’s trial illnesses may not be due to Covid-19 shot, says Oxford University – Hindustan Times
The vaccine trials have resumed in Britain, Brazil and South Africa, but not yet in the United States.
The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s Covid-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
Also read:Oxford’s coronavirus vaccine AstraZeneca trial resumes after UK green light
Enrollment in the British drugmaker’s global trials of the vaccine, which it is developing with researchers at Oxford University, was paused on Se…
-
Noosa News22 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News22 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General23 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General21 hours ago‘World-first’ deal to give delivery drivers better pay